Clinical Trials
2 trialsNCT05370235 2023-09-21
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown
NCT05159752 2023-06-18
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown